# Virtual Biotech Session
**Run:** 20261021-204038-round-2-of-the-b7-h3-cd276-case-a9b7a6f8
**Session:** 86aa9b68-4073-406f-aa9d-d2d1efcbcfdc
**Started:** 2026-10-21T20:41:03.469558
**Last updated:** 2026-10-22 00:49:13
**Total cost:** $32.72

## Turn 1
**User:** Round 2 of the B7-H3 (CD276) case study was interrupted mid-execution by a transient API connection error, not a data or code problem. Before doing anything else, read this resume file in full: /mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/b7h3_round2_20261021/config/resume_after_interruption_3.md -- it tells you exactly what is already done and verified (reuse directly, do not redo), what was in progress when the interruption hit (verify what exists on disk, resume rather than restart), and what has not started yet. The original scope/rules file is still at /mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/b7h3_round2_20261021/config/full_requirements.md if you need to check any detail not covered in the resume file. State briefly that you have read the resume file, then continue execution: finish Wave 2 (LIANA 4D/S5A, cell2location 4E/S5B), then proceed through the spatial-neighborhood analysis, the scientific-reviewer pass (checking underlying data/scripts/figures directly, not just report prose), and final synthesis. No approval checkpoint needed this time -- proceed straight through to delivery.

**CSO:** I'll start by reading the resume file in full.

I've read the resume file. Key takeaways: cell2location training/mapping is complete and verified (2,300/3,000 epochs on CPU — do not retrain); the remaining work is the spatial-neighborhood analysis, panel figures/diagnostics (scripts exist, may need `ROOT` fixed), the 4E/S5B report, the scientific-reviewer pass, and final synthesis. No quota-compromising copies, no approval checkpoint.

Let me verify the actual on-disk state before delegating.

My cwd (`a9b7a6f8`) is fresh/empty, while the predecessor run with the verified work is `ef6e8b35`. Let me inspect both before deciding where to work.

No `code/scripts` in `ef6e8b35`. Let me locate the referenced scripts and inspect the single-cell-analyst workspace.

Scripts live under `work/single-cell-analyst/code/scripts/`. Let me inspect the workspace and remaining-work scripts (avoiding `/dev/null` per the hook).

Now I understand the layout: all prior work lives in `ef6e8b35`; my fresh `a9b7a6f8` dir is empty. The resume explicitly directs continuation in `ef6e8b35`, so I'll operate against that tree. Let me check quota, the plan/claims state, and the remaining-work scripts.

Quota is fine (~14 GB headroom). The plan has s1/s2 done, s3 (neighborhood) and s4 (reviewer) remaining. Let me inspect the four remaining-work scripts and their `ROOT` constants.

`common.py` already points `RUN` at `ef6e8b35`, so `ROOT` is not stale. Let me check the three figure/diagnostic scripts.

All four scripts resolve paths through `visium_c2l_common.py`, which already points at `ef6e8b35` — no stale `ROOT` fix is needed. Before delegating, I'll load the run-organization contract.

Skill loaded. Two things to reconcile: the skill/provenance default to my new run dir (`a9b7a6f8`), but all verified data lives in `ef6e8b35`. I'll test whether provenance honors an explicit `run_dir` so claims can cite the real artifacts. In parallel, I'll load the scope spec and recover the original cell2location task prompt.

Provenance rejected the explicit `run_dir`, so I need to understand its scoping before deciding where to execute. Let me diagnose it and also fix the trace extraction.

Provenance is hard-scoped to my session cwd (`a9b7a6f8`, n=0). Let me read its resolver to see whether symlinked or explicit paths can bridge to `ef6e8b35`, and extract the full original task prompt.

`VBT_RUN_DIR` hard-locks provenance to `a9b7a6f8`. Let me check whether the manifest scanner follows symlinks — if so, I can bridge the existing `work/` tree into the new run with zero-copy symlinks and keep full provenance.

Manifest scanning resolves real paths, so symlinks won't bridge runs. I'll make `a9b7a6f8` the self-contained delivery run, copying only the small verified inputs (3.2 MB h5ad + 0.9 MB parquet + logs) — no large `work/` copy. First, a full inventory of upstream outputs and key file schemas.

Both ELBO history CSVs are header-only (6 bytes) — a documented scvi-tools logger issue captured in the run log, so diagnostics must report convergence as unavailable rather than fabricate a curve. Now let me verify the parquet schema the remaining scripts depend on.

Schema is complete (47,448 spots × 22 sections × 5 patients; 14 cell types, mean + q05). I'll now stand up `a9b7a6f8` as a self-contained delivery run by copying only the small verified inputs and scripts — no large `work/` tree.

The hook rejected the compound script. Let me isolate with a minimal command.

Single copies work. I'll copy the rest in batches.

`a9b7a6f8` is set up (4.3 MB, quota healthy). One dependency to verify before dispatch: the panel script reads `small.obsm["spatial"]`.

`obsm["spatial"]` is present, so the panel script will run as written. Filing the revised plan for this run.

Plan filed. Before dispatch, let me check whether the Lightning logs in the source run contain recoverable ELBO metrics (the history CSVs are empty).

The full mapping run left a 67 KB `metrics.csv` — ELBO may be recoverable. Let me check its schema.

Mapping ELBO is recoverable (3,000 epochs, 104.1M → 38.6M); reference ELBO is not (logger disabled). I'll pass this distinction to the specialist. Dispatching the remaining cell2location work now.

The specialist reports a **forced deviation**: the inherited abundance exports were 100% NaN (a real export bug), so it re-ran only the spatial mapping with identical config (final ELBO within 0.04%) and preserved the invalid files. I need to verify that claim and the new outputs before the reviewer pass.

Verified independently: the inherited parquet was **100% NaN** (1,328,544/1,328,544 abundance values), while the corrected export has 0 NaN and identical metadata/CD276 values. The re-run was justified. Now let me verify the corrected h5ad and inspect the diagnostics/robustness tables.

Verified: corrected h5ad/parquet have zero NaNs, and the run log honestly records the audit, re-run, synthetic probe, and a composition-table correction. Key caveats are real: CD276 is zero in 71–98% of spots (rank fallback in all 22 sections), high-CD276 spots are 1.76× deeper, and interior-only spots reverse most tumor signs. Let me read the full report and inspect the figures.

Let me inspect the key figures before dispatching the reviewer.

Figures are non-degenerate and consistent with the report. Now let me map the full artifact set before dispatching the reviewer.

An interim review of six panels already exists. Let me read the rest of it to carry forward its required fixes.

The interim review (six panels) is complete; the cell2location/4E/S5B scope is still unreviewed, and none of its six required recomputations have been applied upstream. I'll dispatch the full review now.

The reviewer returned "revise and resubmit" with material prose/table defects. Let me read its required-recomputation list before sending the fixes back.

Quota is fine (~13.9 GB headroom). Dispatching the revision to the analyst with the reviewer's Priority 1–4 list.

The revision is back. Let me verify the corrected outputs directly rather than trusting the summary.

The corrected tables verify. Let me look at the regenerated neighbourhood figure and the revised bottom line.

Report revision is sound. Now I'll assemble the upstream panels' artifacts into the live run so the synthesis can cite evidence that validates here.

Upstream artifacts are in place and the revised files survived the copy. Now I'll apply the remaining panel corrections in parallel across the three owning agents.

Both responses are preserved in one file. Now dispatching the targeted re-review of all revisions.

Re-review verdict is accept-with-disclosed-limitations, contingent on small text/artifact fixes. Dispatching those now.

The review→revision loop is closed. Updating progress and reading the remaining panel reports for synthesis.

All corrections verified; the review loop is closed. Let me re-check the deliverable requirements before writing the final synthesis.

Now writing the final synthesis report.

Now filing the 22 claim–evidence objects.

Turn interrupted: Reached maximum number of turns (100) Evidence coverage is incomplete.

**Cost:** $32.72 (cumulative: $32.72)
**Agents:** single-cell-analyst, scientific-reviewer, genomics-analyst, functional-genomics-analyst

### CSO Reasoning
> Let me start by reading the resume file in full as instructed.

> Let me read the resume file carefully.
> 
> Key points:
> 1. Run died due to API connection error. cell2location training/mapping already completed successfully on CPU - DO NOT retrain.
> 2. Verified outputs on disk:
>    - `work/single-cell-analyst/data/processed/visium_c2l_abundances_small.h5ad` (3.2 MB)
>    - `work/single-cell-analyst/results/tables/visium_c2l_spot_abundances.parquet` (926 KB) - 47,448 spots, 22 sections
>    - `work/single-cell-analyst/results/tables/visium_c2l_mapping_history.csv`
>    - `work/single-cell-analyst/results/tables/visium_c2l_run_log.csv` - 3000/3000 epochs
> 3. Remaining work:
>    1. Spatial-neighborhood analysis - script exists: `code/scripts/visium_c2l_30_neighborhood_analysis.py` - fix ROOT path, run
>    2. Panel figures: `code/scripts/visium_c2l_40_panels.py` (fig4e_c2l_tumor, figs5b_c2l_adjacent_normal), `code/scripts/visium_c2l_41_neighborhood_figures.py` (fig4e_neighborhood_immune_change), `code/scripts/visium_c2l_42_diagnostics.py` - fix ROOT, run
>    3. Final report `results/reports/visium_c2l_panels4e_s5b_report.md` - not written
>    4. Check trace.jsonl around 11:40-14:27 for original task prompt if needed
>    5. Scientific-reviewer hasn't started - dispatch after single-cell-analyst's remaining work done
>    6. Final synthesis, panel-by-panel comparison, workflow diagram, README/repo update + push
> 4. Disk quota: check `beegfs-ctl --getquota --uid $(whoami) --csv` before large writes. Do NOT copy work/ tree.
> 5. No approval checkpoint needed.
> 
> Wait - the resume file references a different run directory: `20261021-113551-round-2-of-the-b7-h3-cd276-case-ef6e8b35` but I'm in `/mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/20261021-204038-round-2-of-the-b7-h3-cd276-case-a9b7a6f8`. Hmm, the resume file says "You are already working directly in this run's own directory (`...ef6e8b35`)". But my working directory is `a9b7a6f8`. Let me check the actual state of the working directory. The resume file may be from
> *... [3,455 chars total]*

> Interesting. My current working directory `a9b7a6f8` is empty of work (only empty dirs). The predecessor run with all the work is `20261021-113551-round-2-of-the-b7-h3-cd276-case-ef6e8b35`. The resume file says "You are already working directly in this run's own directory (`...ef6e8b35`)" — it seems the resume file was written assuming the working directory is ef6e8b35. But I'm in a fresh run directory a9b7a6f8.
> 
> Hmm. This is a "round 2 of the B7-H3 (CD276) case study" run, and it's a fresh run that was just created at 20:40. The resume file is in the shared config dir `runs/b7h3_round2_20261021/config/`. It tells me not to copy the full work/ tree (quota crisis) and says everything is already in the ef6e8b35 directory.
> 
> But my MANIFEST.json is in a9b7a6f8. The provenance tools infer run_dir from cwd. If I work in a9b7a6f8, artifacts must be there. The resume says "You are already working directly in this run's own directory (...ef6e8b35); there is no need to copy anything from an older run at all this time". That conflicts with my cwd being a9b7a6f8.
> 
> Let me check the MANIFEST.json in my current dir and the one in ef6e8b35. Also check whether maybe a9b7a6f8 is a fresh orchestration run meant to continue the work, and the work should be done in ef6e8b35? Or maybe the intended approach is to work in ef6e8b35 directly (i.e., cwd should be there).
> 
> Actually, since the resume file says "You are already working directly in this run's own directory (`...ef6e8b35`)", perhaps the harness was supposed to launch me in ef6e8b35 but instead created a new run dir. Let me inspect both MANIFESTs and the directory contents.

> There's no `code/scripts` in ef6e8b35. Let me look at where the scripts are. The resume file references `code/scripts/visium_c2l_30_neighborhood_analysis.py` — maybe relative to a different directory. Let me search for these scripts.
> 
> Also, the new run `a9b7a6f8` has an empty work dir. The resume file says to work in ef6e8b35. Given provenance tooling infers run_dir from cwd, but the objective is to continue the work. I think the cleanest approach:
> 
> Option A: Work directly in ef6e8b35 (cd there). The resume file explicitly says "You are already working directly in this run's own directory (`...ef6e8b35`)". But my actual cwd is a9b7a6f8. Provenance tools would infer run_dir from cwd; if I cd to ef6e8b35, they'd register there. But the harness may expect the run output in a9b7a6f8.
> 
> Option B: Symlink or bind the work tree into a9b7a6f8. Symlinking is cheap (no copy, no quota). That would let the new run have the previous work visible while working in a9b7a6f8. But provenance records artifact paths via SHA/mtime; symlinks might work. However, symlinked directories might confuse the manifest.
> 
> Option C: Just work in ef6e8b35 directly for the remaining analysis, then copy final deliverables (reports, README) into a9b7a6f8. But that duplicates effort...
> 
> Let me check the scripts' actual location first. Search the filesystem for visium_c2l_30_neighborhood_analysis.py.

> The hook blocked because of `/dev/null` in my command. I'll avoid redirecting to /dev/null. Let me redo the listing without /dev/null.

> Good. The work tree exists in ef6e8b35. Now I need to decide: work in a9b7a6f8 or ef6e8b35?
> 
> The resume file says everything needed is already in ef6e8b35, and to continue working there. But my current run directory a9b7a6f8 is fresh. Hmm.
> 
> Important: The resume says "You are already working directly in this run's own directory (`...ef6e8b35`); there is no need to copy anything from an older run at all this time -- everything needed is already here on disk". The resume writer clearly expected the new session to operate directly in ef6e8b35. The new run directory was auto-created by the harness because this is a new session.
> 
> Actually wait — the resume file's claim "You are already working directly in this run's own directory (ef6e8b35)" suggests the harness was expected to set cwd to ef6e8b35. But it didn't; it created a9b7a6f8. This might be a harness behavior where each session gets its own run dir.
> 
> What should I do? Options:
> - Option A: Work in ef6e8b35 by cd'ing there. Provenance tools will infer run_dir from cwd. But if the harness audits a9b7a6f8 at the end, it'd be empty. However, the resume explicitly says the deliverable is in ef6e8b35 and the README/repo update is there. The final README.md and audit.html already exist in ef6e8b35 (from the auto-audit at 14:30). Continuing there is most consistent with the resume.
> - Option B: Work in a9b7a6f8, and establish access to ef6e8b35's work tree via symlinks. Symlinks are cheap (no quota). Then provenance records artifacts under a9b7a6f8/work/... which point to ef6e8b35 files via symlink. But the manifest scanning may resolve symlinks or not — risk of hash/mtime weirdness, and duplicated paths. Also the user asked "continue execution ... to delivery"; delivery likely means the run directory that's active.
> 
> Hmm. The safest interpretation: The resume file was written by the previous orchestrator (or the human), and explicitly addresses me as working in ef6e8b35. It also says not to copy. The
> *... [4,096 chars total]*

> Quota: 200,777,277,440 bytes used out of 214,748,364,800 hard limit = ~200.8GB / 214.7GB, so ~14GB headroom. Good.
> 
> Plan exists with steps s1 (LIANA 4D/S5A), s2 (cell2location), s3 (neighborhood), s4 (reviewer). s1 and s2 are done (LIANA report exists, cell2location outputs exist). Remaining: s3, s4.
> 
> Now let me read the remaining-work scripts to check ROOT constants. Let me read the 30, 40, 41, 42 scripts and common.py.

> The common.py RUN constant correctly points at ef6e8b35. The neighborhood script uses WORK from common. So ROOT is already correct — no fix needed. Good.
> 
> Now let me read the three figure/diagnostics scripts to check their constants.

> All scripts point at ef6e8b35 via common.py — no ROOT fix needed. Good.
> 
> Now, before my first delegation I must invoke the `run-organization` skill per system prompt. Let me do that. Also, I should set up a todo list for tracking.
> 
> Plan for this turn:
> 1. Invoke run-organization skill (required before first delegation).
> 2. Read full_requirements.md for context (maybe delegate? No, I should know scope to write good delegations). Let me read it — it's a config file, allowed.
> 3. Delegate to single-cell-analyst to run the neighborhood analysis (s3) + panels (4E/S5B) + diagnostics + write report. The specialist should invoke evidence-citation skill.
> 4. Then dispatch scientific-reviewer (s4) to inspect data/scripts/figures across ALL specialists.
> 5. Then synthesize, panel-by-panel comparison, workflow diagram, README/repo update and push.
> 6. Record claims, update plan/manifest.
> 
> Important: The system prompt says I'm CSO and should not run analysis myself. The resume says "inspect it, fix ROOT, then run it" but as CSO I should delegate execution to single-cell-analyst. The task instruction says "continue execution: finish Wave 2 (LIANA 4D/S5A, cell2location 4E/S5B), then proceed through the spatial-neighborhood analysis, the scientific-reviewer pass..., and final synthesis." Delegation is the right approach.
> 
> However, there's a nuance: the work must happen in ef6e8b35, but my cwd is a9b7a6f8. The sub-agents' Bash tools likely inherit cwd a9b7a6f8. I must explicitly instruct them to `cd` / use absolute paths in ef6e8b35. The scripts already use absolute paths via common.py. I'll instruct the specialist to run commands with `cd $RUN && ...` and write outputs there. Also provenance tools accept run_dir; but specialists' register_artifact may infer from cwd — they can pass run_dir explicit? The register_artifact schema has run_dir optional. I'll tell them to pass run_dir=ef6e8b35 where available. Actually, `register_artifact` in the specialist tool l
> *... [3,731 chars total]*

> I've read the run-organization skill. The skill says "Every session gets one directory. You are working inside it now." That's a9b7a6f8 per the skill base dir. Hmm, but the resume says work in ef6e8b35.
> 
> This is a real tension. The run-organization skill is loaded from a9b7a6f8/.claude/skills, and says the run directory is a9b7a6f8. The provenance MCP will infer run_dir from cwd = a9b7a6f8.
> 
> The resume file says everything is on disk in ef6e8b35, don't copy. So the right reconciliation: the *analysis artifacts* live in ef6e8b35; but the new session's run directory is a9b7a6f8. If provenance is scoped to a9b7a6f8, then claims citing ef6e8b35 paths may fail validation ("path does not exist" relative to run dir). Unless I pass run_dir=ef6e8b35 to provenance tools, which the tool schema supports.
> 
> The cleanest approach that satisfies both:
> - Perform the remaining work directly in ef6e8b35 (where data is), via sub-agents using absolute paths.
> - For provenance calls, pass run_dir=ef6e8b35 explicitly so claims/plan land with the artifacts they cite and validate.
> - Also mirror the final deliverables into a9b7a6f8? That would duplicate large files. Better: a9b7a6f8 gets a README/pointer explaining the run continues in ef6e8b35 (tiny text files), or symlinks for the report/figures. But README.md is generated by harness; I shouldn't hand-edit in ef6e8b35 per skill ("do not hand-edit"). Hmm, but the resume says "README/repo update and push -- not started", implying I should update README. In ef6e8b35 README.md was auto-generated at 14:30. Maybe the pipeline regenerates it. The skill says generated, don't hand-edit. So "README/repo update and push" likely refers to the *repository* README (the git repo), not the run README. Let me check the git repo structure — cwd is a git repo (TheVirtualBiotech). The run dirs are inside the repo? Let me check.
> 
> Actually, `git_commit: 71f9da68` in MANIFEST; cwd `/mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/20261021-
> *... [3,208 chars total]*

> The provenance tool rejects explicit run_dir because it only works from within a run workspace (cwd containing MANIFEST.json). So to use provenance, I must run from ef6e8b35. But I can't change my own process cwd for tool calls; the MCP server infers from... maybe the server's working dir is fixed at start (a9b7a6f8). Hmm. The tool said "This tool must be called from within a run workspace (a directory containing MANIFEST.json)". My cwd is a9b7a6f8 which DOES have MANIFEST.json. So why "No run directory found" when I passed run_dir=ef6e8b35? Maybe because the explicit run_dir isn't recognized (only cwd-based). Or perhaps the server's cwd is something else (e.g., repo root). Let me test without run_dir: call list_artifacts() with no args. If it works, it's scoped to a9b7a6f8 (which has empty artifacts).
> 
> Actually the error says "No run directory found" — that suggests the explicit path handling requires MANIFEST.json in that dir; ef6e8b35 has MANIFEST.json. Unless it doesn't accept absolute paths? Let me test both: list_artifacts() (no args) and list_artifacts(run_dir=".") etc.
> 
> The trace extraction didn't work because the trace record types differ (line 98 type tool_start, line 507 agent_stop, 560 tool_end). Let me print those records.
> 
> Key decision on run dir: Since provenance only works within the run workspace, and my session's run workspace is a9b7a6f8, the proper approach per the skill is to work in a9b7a6f8. But then the verified artifacts are outside. I could create symlinks in a9b7a6f8/work/single-cell-analyst → ef6e8b35/work/single-cell-analyst. Symlinks are cheap and would make the artifacts visible under the run dir without copying. But would provenance validate symlinked paths? It resolves paths against MANIFEST.json probably; MANIFEST is empty in a9b7a6f8. Hmm.
> 
> Alternative: make a9b7a6f8 the actual run by symlinking individual subdirs, and register artifacts via register_artifact. But provenance validation is against MANIFEST.json, whic
> *... [4,146 chars total]*

> Key finding: provenance is scoped to the session cwd (a9b7a6f8) and the explicit run_dir didn't work (probably it validates the path as a workspace but then uses cwd elsewhere, or it doesn't accept absolute paths outside? Let me look at the tools.py code to understand). But fundamentally, `list_artifacts()` with no args returned run_id a9b7a6f8, n=0.
> 
> Let me read the provenance tools code lines around 60-100 to understand how run_dir is resolved. Maybe it uses `run_dir or os.getcwd()` and then checks MANIFEST; my explicit path should have worked. Unless it resolves the explicit path relative to cwd and then requires existence of MANIFEST.json... which exists. Let me look.
> 
> Also, the trace prompt is truncated at 6000 chars. I need the rest of the prompt (Task B onwards + Task C neighborhood + Task D report). Let me extract the full prompt from line 98 into a file or print more. I'll print the full tool_input prompt.
> 
> Also important context from the trace:
> - The original agent got the full spec, and it's exactly what the resume summarized.
> - Python: /home/xqinag/miniconda/envs/vbt/bin/python
> - Scripts under code/scripts point at current run now (common.py fixed).
> - The cell2location agent completed at 14:27:07, per trace tool_end. But wait — the resume says a detached nohup process kept running and finished at 15:08. The parent died at ~14:30. So the agent returned "completed" at 14:27 but data finished at 15:08. The mapping log has 3000 epochs.
> 
> I need the full original prompt to give the specialist exact remaining instructions. Let me extract it fully to a temp file in /tmp? The hook blocks paths outside allowed dirs. I can write into the run dir (a9b7a6f8) or ef6e8b35. I'll write to ef6e8b35/work/_cso/ maybe. Actually simpler: print with a higher limit (say 20000 chars) in chunks.
> 
> Let me also read the provenance tools code.
> 
> And let me check the LIANA report quickly to know what's done (I'll need it for synthesis). But the scientifi
> *... [2,932 chars total]*

> Now I understand `_find_run`: it walks up from `start` (explicit run_dir) and finds first dir with MANIFEST.json. But there's a constraint: if `VBT_RUN_DIR` env is set, `cand != Path(bound).resolve()` → return None. So the server has `VBT_RUN_DIR` set to a9b7a6f8, which forces it to only accept a9b7a6f8. That's why explicit ef6e8b35 failed.
> 
> So provenance is hard-locked to a9b7a6f8. Therefore, to file claims, the artifacts must be under a9b7a6f8 and recorded in a9b7a6f8's MANIFEST.
> 
> Options:
> 1. Work wholly in a9b7a6f8 by symlinking `work` → ef6e8b35/work. Then _find_run(a9b7a6f8) works. `m.scan()` walks the run dir; if work is a symlink, does scan follow it? Let me check RunManifest.scan. If it uses os.walk, by default it does NOT follow symlinked dirs. That means artifacts under symlinked work wouldn't be recorded. Bad.
> 
> 2. Copy the needed final artifacts (small CSVs/figures/reports) from ef6e8b35 into a9b7a6f8 for provenance, while keeping analysis in ef6e8b35. The large h5ads stay put. The report/figures/tables are small (tables total ~147MB dominated by 114MB DE csv; we only need the c2l/neighborhood ones ~ a few MB). That's acceptable quota-wise. But it duplicates files and creates confusion about which is authoritative.
> 
> 3. Treat ef6e8b35 as the authoritative run and ignore provenance scoping; file claims with paths that exist in ef6e8b35 by... impossible due to VBT_RUN_DIR lock.
> 
> 4. Set up a9b7a6f8 as the run dir but bind-mount? Can't (no root).
> 
> 5. Since VBT_RUN_DIR is read from env inside the MCP server process (fixed at startup), can't change.
> 
> Hmm. But wait — maybe the environment variable is only set for the provenance MCP server started with the session. The `_find_run` bound check: if bound env is set and cand != bound, return None. Could I pass run_dir="." from a9b7a6f8? That resolves to a9b7a6f8 and works. So yes, only a9b7a6f8.
> 
> Given the skill's philosophy ("Every session gets one directory. You are working inside 
> *... [4,133 chars total]*

> Critical: line 289: `if not p.is_file() or not p.resolve().is_relative_to(self.run_dir.resolve()): continue` — so files whose real path is outside the run dir are skipped. Symlinks would resolve to ef6e8b35 and be skipped. So symlinking doesn't work for manifest.
> 
> Therefore, to have provenance in a9b7a6f8, files must physically live under a9b7a6f8. Copying only the small cited outputs (~50MB, not the 6GB h5ads) is acceptable and does not violate "do not copy the full work/ tree" (which was about ~7-8GB of h5ads). But duplication could confuse the audit.
> 
> Hold on. Let me reconsider whether to just work in a9b7a6f8 entirely for the remaining analysis:
> - The neighborhood analysis needs `visium_c2l_spot_abundances.parquet` (926KB) and `visium_c2l_abundances_small.h5ad` (3.2MB). Tiny! I can copy those into a9b7a6f8 as *input* files. No need for the 6GB h5ads. The neighborhood analysis writes new tables/figures.
> - The panel figures need `visium_c2l_abundances_small.h5ad` (3.2MB) and the spot abundances parquet (926KB). Tiny.
> - Diagnostics need mapping/reference history CSVs (small).
> - The report is new.
> - So all remaining analysis can run entirely in a9b7a6f8 with ~5MB of input copies.
> 
> For final synthesis claims citing upstream artifacts (LIANA, scRNA, TCGA, Tahoe, Visium QC), the evidence files are tables (~150MB total, but the huge 114MB DE file can be avoided; cite the top-genes table 48KB instead) and figures (~34MB, dominated by a 28MB PDF and 5MB PNG UMAP; could cite the PNGs or smaller versions). Copying those into a9b7a6f8 would cost maybe 10-40MB — fine. But it duplicates and may be seen as re-copying. Alternatively, cite only the *new* artifacts in a9b7a6f8 and reference older run artifacts by path in prose (not as claim evidence)? But the skill says every substantive assertion should have evidence; evidence must exist in this run. Hmm.
> 
> Wait — maybe there's a better way: the final synthesis could be delivered in ef6e8b35 (where everyt
> *... [9,444 chars total]*

> Key facts:
> - Both history CSVs are header-only (6 bytes) because scvi-tools 1.4 with logger=False populated no history. The run log documents this explicitly (reference_train_correction row). So diagnostics will report "no elbo_train" — that's an honest, documented limitation. The diagnostics script handles it gracefully. Good.
> - Mapping: 3000/3000 epochs, 7134.4s, CPU, 47,448 spots, 1926 genes, N_cells_per_location=8, detection_alpha=20.
> - Reference: 250/250 epochs, 4586.9s, CPU, 384,806 cells, 2000 genes.
> 
> Now let me inspect the parquet schema to ensure the neighborhood script's required columns exist (CD276_lognorm, q05_*, mean_*, array_row/col, section, patient, histology). And the small h5ad obs.
> 
> Then set up a9b7a6f8 copying only small inputs, and delegate.
> 
> Let me check parquet columns and a few rows; also confirm number of rows = 47,448 and sections=22, histology counts. Reading a few rows is inspection, fine.
> 
> Also I should read the LIANA report and other reports for synthesis later. Let me first do setup and delegation; reading reports can happen while specialist runs? No, subagent runs block. I can read them before delegating to craft better reviewer instructions. Let me read the three reports (liana, scrna, visium QC, genomics 4a, clinical 4f, tahoe) — that's ~100KB total, fine. But as CSO, my job is synthesis; reading is appropriate.
> 
> Actually, to keep context manageable, I'll read the key reports after the specialist finishes, or have the reviewer handle detailed verification. For delegation, I need enough to specify tasks. The original prompt gives that.
> 
> Setup plan for a9b7a6f8:
> 1. Create `work/single-cell-analyst/{code/scripts,data/processed,results/{tables,figures,reports},logs}` dirs.
> 2. Copy the 5 scripts (common, 30, 40, 41, 42) into code/scripts.
> 3. Copy inputs:
>    - data/processed/visium_c2l_abundances_small.h5ad (3.2MB)
>    - results/tables/visium_c2l_spot_abundances.parquet (926KB)
>    - results/tables
> *... [3,529 chars total]*

> The heredoc with python: R wasn't exported into python. Fix by hardcoding path.

> Schema is complete: 47,448 spots, 22 sections, 5 patients, tumor 27,826 / adjacent-normal 19,622. 14 cell types with mean and q05. All required columns present.
> 
> Now set up a9b7a6f8 with the small inputs and scripts. Then delegate to single-cell-analyst. Let me create the todo list too.
> 
> Setup commands (copy only small files):
> - mkdir -p work/single-cell-analyst/{code/scripts,data/processed,results/{tables,figures,reports},logs}
> - cp scripts
> - cp data files (h5ad 3.2MB, parquet 926KB)
> - cp tables (run log, histories, reference prep/signature tables)
> - cp logs (c2l_mapping_full.log, c2l_reference_train.log, c2l_env_setup.log, c2l_compute_and_api_log.md, c2l_benchmark.log, c2l_mapping_benchmark.log, c2l_mapping_smoke_test.log)
> - Also copy visium QC tables/figures? The report needs per-section QC summary. Files: visium_section_qc_inventory.csv (2.5KB), visium_qc_threshold_sensitivity.csv, visium_spot_qc_metrics.csv (7.7MB), visium_ingest_qc_log.md (11KB), visium_barcode_matching.csv, visium_file_verification.csv. Copy the small ones (skip 7.7MB? It's small enough, but only needed for QC summary—already summarized in section inventory). I'll copy section inventory + ingest log + threshold sensitivity + file verification + barcode matching.
> - Also copy visium QC figures? Not necessary for remaining work; the report may reference them. Could copy 4 small PNGs (~260KB total). Fine.
> 
> Then instruct specialist to edit common.py RUN to a9b7a6f8 and ensure LOG path etc.
> 
> One more consideration: the script `visium_c2l_40_panels.py` line 56 `obs["T_cell_abundance"] = obs["mean_T cell"]` — column name with space works. It groups by histology; fine.
> 
> Potential issue: `visium_c2l_41_neighborhood_figures.py` uses `np.random.default_rng(0).normal(...)` fine.
> 
> Potential issue in 30: `df.index.name = "spot_barcode"` then `sub = df[df["section"]==sec]`; `xy = sub[["array_row","array_col"]]`; KDTree. Fine. q05 columns exist. It builds neighbor_store. 
> *... [5,221 chars total]*

> 

> The hook blocks `du -sh`? Or the `find` with `%p` absolute paths? It says "Command references path outside allowed directories: /". Maybe the hook parses for absolute path tokens starting with `/` and rejects certain ones. Earlier commands with absolute paths worked though. The issue may be `du -sh $DST` expanding to /mnt/... (allowed) — hmm "outside allowed directories: /" with only "/" suggests the parser saw a bare `/` token. Where? `cp ... /`? No. Maybe `sort -k2`? No.
> 
> Possibly the `-printf '%s\t%p\n'` includes a backslash-t; no.
> 
> Could be the multiline script and the hook only scans the first line? It says path outside allowed dirs "/". Maybe `mkdir -p $DST/...` fine. `cp ... $DST/` fine.
> 
> Maybe the issue is `du -sh $DST` → hook's parser sees `/` from `-sh`? Unlikely.
> 
> Earlier my successful command had `find $R/work -path ... | sed "s#$R/##"`. This one has `cp` with many absolute paths but all under /mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/... which are allowed. The hook may allow only cwd subtree? But earlier reads of ef6e8b35 succeeded. Hmm, the earlier `find`/`cat` commands on ef6e8b35 worked.
> 
> Maybe the specific trigger is `set -e`? No.
> 
> Let me simplify: run commands one at a time, avoid `set -e`, avoid `du -sh` maybe. Also avoid `-printf`. Let me just do mkdir + cp in a simple chain, then ls.
> 
> Actually the error "Command references path outside allowed directories: /" likely comes from a path token exactly "/". In my script: `sort -k2` no. `%s\t%p\n` no. `du -sh $DST` no. Hmm, `find $DST -type f -printf` — the format string contains `/`? No.
> 
> Wait: `mkdir -p $DST/code/scripts $DST/data/processed ...` — if $DST were empty, it'd be `/code/scripts` → outside. But DST is set. Unless the hook scans the literal text before variable expansion and sees `$DST/code/scripts`? No slash at start.
> 
> Maybe the hook rejects `cp` from a source outside the current run dir? It says "outside allowed directories: /" — the allowed d
> *... [2,211 chars total]*

> Good, relative paths work. Now copy files using relative destination and absolute source but with `cd` to the source? Maybe the hook dislikes absolute source paths? Earlier absolute reads worked. Let me try a single cp with absolute source and relative dest.

> Single cp works. The earlier failure might have been due to one of the destinations (`$DST/...`) or `set -e`? Let me just do a series of cp commands with the `$SRC` variable and relative dests. I'll batch them with && but avoid `du`/`find -printf`. Let me try multiple cp in one command.

> Now verify the tree and total size. Use `du -sh work/single-cell-analyst` (relative).

> 4.3MB total, quota fine (13.97GB headroom). 
> 
> Now, before dispatching, write the plan to a9b7a6f8. Steps:
> - r1: single-cell-analyst — complete c2l panels (4E/S5B), diagnostics, neighborhood analysis (s3), report. depends_on [].
> - r2: scientific-reviewer — full evidence-level review across all panels (4A, 4B/4C, 4D/S5A, 4E/S5B, 4F) using both a9b7a6f8 and read-only ef6e8b35. depends_on [r1].
> Maybe also r0: single-cell-analyst verify carried-forward inputs (already did myself; no).
> I could include a step for "final synthesis" but that's mine.
> 
> Let me call write_plan. Use relative expected outputs.
> 
> Then dispatch single-cell-analyst. The prompt must be self-contained, detailed, and include:
> - Context: resuming interrupted run; do not retrain/re-run cell2location; reuse verified outputs.
> - Run dir: /mnt/.../a9b7a6f8 (write here). Source read-only: ef6e8b35.
> - Python: /home/xqinag/miniconda/envs/vbt/bin/python
> - First: invoke evidence-citation skill.
> - Fix ROOT in visium_c2l_common.py: RUN = a9b7a6f8 (currently ef6e8b35). Note: scripts write to WORK/results; LOG appends to run log. Keep the copied run log intact (it's the provenance record), append new rows.
> - Task 1: run diagnostics (42) — note history CSVs are header-only; report convergence as unavailable; do not fabricate. It writes training_convergence.csv (may be empty rows or headers), abundance_sanity.csv, figs5_c2l_training_convergence.png (will show "no elbo_train" panels). Fine.
> - Task 2: run panels (40) — fig4e_c2l_tumor, figs5b_c2l_adjacent_normal, section_summary.
> - Task 3: run neighborhood analysis (30) — per pre-specified definitions. N_PERM/N_BOOT default 1000; runtime maybe long; allow env overrides? The original spec requires permutation/label-shuffle null or bootstrap CI. Keep 1000. If too slow, log and reduce with justification (but don't silently downgrade). Expected outputs: visium_neighborhood_immune_change.csv, robustness.csv, stratification.csv, edge_spot_sens
> *... [5,088 chars total]*

> `obsm["spatial"]` exists. Good.
> 
> Now file the plan. Then dispatch single-cell-analyst.
> 
> Plan steps:
> r1 single-cell-analyst: "Complete cell2location 4E/S5B: diagnostics, panels, k=6 neighborhood analysis, and report using verified completed CPU outputs (no retraining)."
> r2 scientific-reviewer: "Evidence-level review of all panels 4A/4B-4C/4D-S5A/4E-S5B/4F by opening data, scripts, figures directly; verify LoF-constraint and Tahoe materiality patterns, LIANA pre-registration timeline, 4E/S5B split, paper fit."
> Maybe r3: single-cell-analyst recomputations (depends on r2) — but I don't know yet. I could add a contingent step r3 with depends_on r2. The plan validator allows. I'll add r3 "address reviewer-required recomputations" depends_on [r2]. That is a real likely dependency.
> 
> Expected outputs paths relative to run.
> 
> Let me call write_plan.

> Plan filed. Now dispatch single-cell-analyst with a detailed self-contained prompt. It must:
> - invoke evidence-citation skill first
> - fix RUN constant in common.py to a9b7a6f8
> - run diagnostics, panels, neighborhood, figures, write report
> - register artifacts
> - not touch ef6e8b35
> - return concise summary
> 
> Let me write the prompt carefully. Include all key facts and expected outputs. Also note: the report must state the epoch deviation and the ELBO unavailability, panel split assumption, per-section summary, neighborhood robustness, limitations, bottom line.
> 
> Also tell it: do not re-run LIANA, scRNA, TCGA, etc. Only c2l panels + neighborhood.
> 
> Also tell it about the copied run log: append, do not overwrite; its first rows are the reference-prep and training/mapping provenance.
> 
> Also: runtime expectations. Neighborhood 1000 perms × 1000 boot might take a while; instruct to run in background with log, poll, and if runtime > ~45 min, reduce N_PERM/N_BOOT to 200 with explicit logging of the downgrade and rationale (not silent). Actually the spec says at minimum a permutation/label-shuffle null or bootstrap CI; 200 perms is weaker. Better: keep 1000 unless infeasible. The script's env vars C2L_NPERM/C2L_NBOOT allow it. Tell it to measure runtime on a small N first (e.g., N_PERM=20, N_BOOT=20) to estimate, then run full 1000 if total < ~60 min, else document and use a justified reduced count (≥200) — no silent downgrade. Good.
> 
> Also caution: "Do not modify the input data files" (h5ad/parquet). Write only new outputs.
> 
> Also: check quota before large writes.
> 
> Also: the diagnostics script expects `epoch` column; histories are header-only → it will produce rows with no elbo? It checks `if "elbo_train" not in h` → sets title and `continue`, so rows appended only when elbo exists. So training_convergence.csv will be empty (headers only). That's fine but the report must explain. Could the specialist recover ELBO from the Lightning logs? The
> *... [2,501 chars total]*

> There is a metrics.csv for bench0_3000ep (67KB) — likely the full mapping run's metrics! Let me inspect the header and first/last rows. If it has elbo_train per epoch, the specialist can recover the convergence curve. Let me check.

> Excellent! The mapping ELBO curve IS recoverable from the Lightning metrics.csv (3000 epochs). The reference training model's logger=False likely produced no metrics, but let me check for a reference lightning dir. `find` only showed c2l_mapping; no reference. So reference ELBO unavailable, mapping ELBO available. This is a meaningful distinction the report should make.
> 
> I should copy this metrics.csv into a9b7a6f8 logs and tell the specialist to use it to produce the mapping convergence plot/diagnostics. The diagnostics script 42 reads `visium_c2l_mapping_history.csv` which is header-only. The specialist should adapt: (a) copy/recover metrics into `visium_c2l_mapping_history.csv` (with columns elbo_train, epoch, step) — but overwriting the copied history file with recovered data is fine if documented (it's a diagnostic input, not a claim). Better: write a new file `visium_c2l_mapping_elbo_recovered.csv` and have 42 prefer it, documenting provenance. The specialist can modify 42 accordingly. I'll instruct.
> 
> Let me copy the metrics.csv into a9b7a6f8 logs (and maybe into results/tables as recovered ELBO). Actually let the specialist copy and register it. I'll just tell it the path in ef6e8b35 (read-only) and instruct it to copy into a9b7a6f8.
> 
> Now dispatch. Let me compose the prompt.
> 
> Key prompt content:
> 
> Context: You are resuming an interrupted run. cell2location training/mapping already completed successfully on CPU; DO NOT retrain or re-run mapping/LIANA/scRNA/TCGA. Only the remaining deliverables for panels 4E/S5B + spatial neighborhoods.
> 
> Run dir (write here): /mnt/beegfs/.../a9b7a6f8
> Read-only source run (older): /mnt/beegfs/.../ef6e8b35
> Work tree: <RUN>/work/single-cell-analyst
> Python: /home/xqinag/miniconda/envs/vbt/bin/python
> Invoke evidence-citation skill FIRST.
> 
> What is already done and verified (do not redo):
> - 22 LUAD Visium sections (12 tumor, 10 adjacent-normal), 47,448 QC-passed spots, from E-MTAB-13530 (De Zuani 2
> *... [6,638 chars total]*

> Important: the agent found the inherited abundance files were 100% NaN! That's a major data integrity issue. It re-ran the mapping with identical config and corrected export (7,769.7s + 204.5s ≈ 2.2 hours). Wait — the resume explicitly said "It already completed successfully... Do NOT retrain or re-run cell2location". But the inherited abundances were all NaN, so the analyst did a forced re-run. It says the final ELBO differs by −0.04% from the original, so it's consistent. It preserved invalid files in data/processed/deprecated_all_nan_export/ and logged a mapping_output_audit failed row.
> 
> But wait: did it also re-train the reference? It says "No reference training, LIANA, scRNA or TCGA was re-run." So it used the existing reference model. Mapping re-run took 7,769.7s (~2.16h) + export. That's plausible.
> 
> Hmm, but earlier I verified the parquet in ef6e8b35 had finite values? I printed head rows: mean_* weren't shown, only metadata columns. I didn't check NaN. The agent says 664,272/664,272 values were NaN in the stored abundance files. 47,448 × 14 = 664,272. Yes, all mean_ and q05_ values NaN. Let me verify this claim on the source parquet. If true, the resume's "verified" claim was wrong, and the re-run was justified and important. I must verify independently because this is a big deviation from the resume. Let me check the source parquet NaN counts and the new parquet.
> 
> Also the agent reports:
> - Mapping ELBO 104,060,600 → 38,571,652; re-run final 38,557,988 (−0.04%). Consistent.
> - Neighborhood results (tumor vs adjacent-normal), with absolute percent changes, but composition analysis shows most changes are density effects; edge-spot sensitivity reverses signs; high-CD276 spots 1.76× deeper. Adjacent-normal high group only 30% CD276-positive, rank fallback used in all 22 sections due to zero ties. Wait: "rank fallback used in 22/22 sections" — for adjacent-normal? It says adjacent-normal high group is only 30% CD276-positive, so the quartile split 
> *... [4,038 chars total]*

> Verified: OLD abundance parquet is 100% NaN (1,328,544/1,328,544 across 28 abundance columns). NEW is 0 NaN. The re-run was necessary and justified. Good.
> 
> Note the new parquet is 8.9MB vs old 926KB (NaNs compress well). Fine.
> 
> Quota now ~200.88GB used; headroom ~13.87GB. Fine.
> 
> There's a `logs/synthetic_test/visium_neighborhood_stratification_synthetic.csv` — a synthetic test artifact. Fine, but it should be described or acknowledged; it's a test, not a finding. The reviewer may flag it. I'll note it.
> 
> Also `visium_c2l_spot_abundances.parquet` now has the corrected data. But the copied `visium_c2l_abundances_small.h5ad` is still the OLD all-NaN h5ad! The panel script 40 reads the small h5ad. Did the analyst regenerate it? The listing shows `data/processed/visium_c2l_abundances_small.h5ad` still there; did it get overwritten with corrected data? Let me check its obs NaN. The file list at tail didn't show data/processed. Let me check. If the panel figures were generated from the all-NaN h5ad, they'd be broken. The analyst said it corrected the export and reran scripts 40 — presumably it regenerated the h5ad too. Let me verify.
> 
> Also check the report content and key tables. Let me inspect:
> - small h5ad NaN
> - training convergence csv
> - abundance sanity
> - stratification audit (rank fallback frequency)
> - robustness key rows
> - edge sensitivity
> - composition sensitivity
> - report (full read)
> 
> Let me do these in parallel. The report is 20KB; read it. Tables are small.
> 
> Also verify the figures are non-degenerate (file sizes look reasonable; could inspect via Read image later). I'll view one or two figures.
> 
> Let me check the h5ad and tables first.

> This is very informative. Key verified facts:
> - Corrected h5ad has 0 NaN.
> - Run log is comprehensive and honestly documents the all-NaN audit, re-run, synthetic tests, composition correction.
> - Stratification audit: because CD276 is zero in 71-98% of spots, q25=0 in every section → no spots < q25 → rank_fallback_required=True in all 22 sections. So the "top/bottom quartile" contrast is implemented as a deterministic rank-based split (top quarter vs bottom quarter), where the bottom quarter is all zeros (CD276-negative) and top quarter are the highest expressers. This is an important methodological deviation from the literal ">75th vs <25th percentile" because of zero-inflation. The report must state this. It does (per the summary).
> - High spots are much deeper: e.g., P10_T1 median counts 13,939 vs 5,581 (2.5×); P16_B2 1,211 vs 915. Overall 1.76×. So depth confounding is substantial.
> - Edge sensitivity: tumor all-spots effects mostly positive; restricting to interior (6-neighbor) spots reverses signs for almost all types (T +15.4→−7.1; DC +28.8→+0.03; macrophage −7.6→−29.1). This is a serious robustness problem — the "positive neighborhood immune enrichment" is largely an edge/compactness artifact. Adjacent-normal remains positive interior (T +9.7, DC +17.2, macrophage +4.0) but CIs likely wide.
> - Relative composition (all spots): tumor DC +9.8% (CI 3.2-17.5, 9/12), endothelial −21.5% (0/12), NK −6.6%, macrophage −12.1%; T cell +1.4% (CI −0.75 to 4.4, marginal). Adjacent-normal macrophage +8.9% (8/10, 4/5), most others slightly negative.
> - Six-neighbor-only relative composition: tumor all types negative (because high spots are in dense regions? The normalization per spot means neighbor total is similar; high spots' neighbors have lower relative fractions of everything? This is confusing but indicates instability).
> - Additive pp endpoint: tumor DC +0.49 pp (9/12, 4/5), endothelial −2.03 pp (0/12), T +0.11 pp (CI −0.10 to 0.38). Adjacent-normal macropha
> *... [6,172 chars total]*

> Let me pick up where I left off: inspect the key figures, then dispatch the scientific-reviewer.
> 
> Let me first check the figures exist and inspect them.

> 

> The figure looks correct — non-degenerate spatial maps, distinct tissue shapes, sensible abundance gradients, composition stacked bars. Let me check the adjacent normal figure and the neighborhood figures.

> 

> 

> Both figures look real and non-degenerate. Note the adjacent-normal figure's panel A shows many categories flagged red because CI excludes 0, but the effects are small (~5-15%) compared to tumor; the tumor figure shows larger effects but also many. Interesting: the neighboring "red = immune (CI excludes 0)" coloring logic in the script actually colors by whether CI excludes zero, not by compartment — in the tumor figure, macrophage (CI includes 0) is gray, fibroblast gray, epithelial gray-ish though epithelial CI seems to exclude 0... let me check: the script sets base = red if immune else grey, then if not sig → "#d5d8dc" (light grey). Epithelial is grey with CI excluding 0? In the figure, epithelial appears grey with a long CI that seems to cross... hard to tell. That's fine.
> 
> One thing: the legend text says "red = immune (CI excludes 0)" which is slightly imprecise, but acceptable.
> 
> Now the training convergence figure.

> All figures look non-degenerate. Now let me dispatch the scientific-reviewer. First, let me update the todo list to reflect progress, then write the reviewer prompt with all the context.
> 
> Let me check the todo list state — I should keep it current. Let me set it up.
> 
> Also I should check what panels/artifacts exist upstream so the reviewer has a precise list. Let me quickly list the upstream results directories.

> Good. Let me also check the reports directories for upstream specialists, and the a9b7a6f8 run's existing content (which includes some copied upstream files?). Let me check what's in a9b7a6f8 work.

> Interesting — there is already `work/scientific-reviewer/scientific_review_interim_panels1-6.md`. That may have been written earlier (from the predecessor context?). Let me check its content and timestamp. It's 36K dir. Let me read it.
> 
> Also I notice upstream specialty reports exist. Let me check timestamps of the scientific-reviewer file.

> There is an interim review of panels 1-6 (4A, 4B/4C, 4D/S5A, 4F, Tahoe, Visium QC) written 22:01. So the reviewer had been dispatched earlier. The remaining full review must cover the cell2location/4E/S5B/neighborhood, and consolidate. Let me read the rest of this interim review to know the required fixes, so I can carry them into the final review/synthesis.
> 
> Let me read the remaining sections, especially the issues list and required recomputations.

> 

> The interim review is very substantive. Now I need to:
> 1. Dispatch a follow-up review covering cell2location/4E/S5B/neighborhood + verifying the fixes applied to the six panels.
> 2. Then handle required recomputations. Actually the required recomputations are mostly in upstream work (ef6e8b35) and not present in live run. Hmm. The live run only has single-cell-analyst work (Visium QC + cell2location). The other agents' outputs are only in the source run.
> 
> I need to decide the delivery structure. The final report must be a self-contained delivery run. Since claims must cite artifacts in the live run (MANIFEST-validated), I planned to copy curated upstream result tables/figures/reports into a9b7a6f8. That's necessary.
> 
> First priority now: the reviewer's remaining scope. Let me dispatch the scientific-reviewer for the cell2location/4E/S5B/neighborhood work plus a verification of whether the required fixes were applied (and check whether the fixes from the interim review have been done — they haven't, since I haven't dispatched them). Wait: were they done? The interim review was at 22:01, and the cell2location work continued to 23:13. The required recomputations list may not have been actioned. Let me check whether any changes appear in the upstream run after 22:01 (files modified after 22:01).
> 
> Let me check upstream files' mtimes after 22:01 today.

> No upstream files modified after the interim review — so the required recomputations have not been applied yet. Hmm, but no output at all could also mean the find syntax issue... let me verify with a different check. Actually `find -newermt` should work. Let me check a known file.
> 
> Actually, the interim review itself is in LIVE. The upstream files were last modified 15:08 or earlier. So the six recomputation items are outstanding.
> 
> Now, the plan: I need to be efficient. Let me:
> 1. Dispatch scientific-reviewer (b) to review cell2location/4E/S5B/neighborhood, and also verify the current live-run consistency (report vs tables), the all-NaN re-map equivalence, figures, etc.
> 2. In parallel or sequentially, dispatch single-cell-analyst to apply the corresponding fixes for the Visium-related items (restore visium_spot_qc_metrics.csv to live, add metadata-integrity note on SDRF age/stage).
> 3. The other fixes (4A, 4B/4C, 4D/S5A, 4F, Tahoe) are in the upstream run. Since the final deliverable is built from upstream artifacts copied into live, I could either (a) dispatch the relevant specialists to apply fixes into the live run's copied artifacts, or (b) have the final synthesis disclose them as known defects. The review says 4A, 4B/4C, 4D/S5A, Tahoe require small corrections. Since delivery quality matters and the user asked to proceed to delivery, I should apply the fixes where they're cheap and consequential. But re-running genomics/functional-genomics/clinical work costs time and they'd need their data which is only in the source run.
> 
> Actually a cleaner approach: copy the upstream result trees (tables/figures/reports) into the live run under each agent's `work/<agent>/results/`, plus the scripts, then dispatch each relevant specialist to apply the correction directly to the copied artifacts (with the source run read-only). But that's a lot of dispatch. The user's instruction: "proceed through ... the scientific-reviewer pass ... and final synthesis." The
> *... [7,274 chars total]*

> 

> The reviewer found substantive defects, including some that contradict claims I had accepted. Notably:
> 
> 1. "Tumour sections are denser" backwards — median total abundance 7.14 adjacent-normal vs 6.42 tumour.
> 2. Percentage-point differences don't sum to ~0 — denominator includes 14 compartments but only 12 reported.
> 3. "NK and endothelial remain negative under edge sensitivity" wrong — endothelial absent from edge table; NK flips.
> 4. mean vs median misuse; ">q75 empty" vs "<q25"; "11 types" vs 12; neutrophil p-value contradiction.
> 5. Adjacent-normal high-CD276 group degenerate (median 0.0 in 8/10 sections).
> 6. No multiplicity correction, permutation null ignores spatial autocorrelation, bootstrap ignores donor clustering.
> 7. Omitted donor-concordant findings.
> 8. CD276 fibroblast origin and normal macrophage positivity not stated.
> 9. 664,272 = 47,448 × 14 not × 28.
> 10. LIVE not self-contained; hardcoded SOURCE path.
> 
> This is exactly the kind of thing the reviewer is for. "Revise and resubmit" — computations largely trustworthy, prose/table interface fails.
> 
> Now I need to dispatch single-cell-analyst to fix these. This is a substantial revision:
> - Correct the report prose against the tables.
> - Fix the composition pp denominator issue (report all 14 compartments or normalize the reported set correctly and state it).
> - Fix the edge analysis script to include all 12/14 types (currently loops IMMUNE_TYPES 9 + context 3 = 12; missing malignant + stromal) and rerun edge sensitivity.
> - Fix the mean/median label bug (or fix computation).
> - Fix "11 types" → 12.
> - Fix neutrophil p contradiction.
> - Make explicit the adjacent-normal degenerate split.
> - Add multiplicity correction or clearly disclose unadjusted p-values (scoping: the report should disclose; optionally add BH-FDR across cell types).
> - Add donor-level summary (0/12 sections, 0/5 donors).
> - Add CD276 normal macrophage positivity and fibroblast origin as safety-relevant
> *... [2,475 chars total]*

> 

> Now I dispatch the single-cell-analyst to apply the fixes (Priority 1-4 for spatial) and self-containment. This is a substantial but tractable revision: re-running composition/edge sensitivity scripts is cheap (tables), not model retraining. Also copy spot QC table + ingest scripts/logs, repoint script, add assertions, fix report prose.
> 
> I must give a precise, self-contained prompt. Include all the reviewer's items and the paths.
> 
> Also note reviewer's "Priority 3 #19: apply interim recomputations 1-6". Some belong to other agents (genomics, single-cell for 4B/4C, Tahoe, clinical). The single-cell-analyst can handle #2 (4B/4C top-genes and batch log) and #6 (Visium spot table + SDRF note) and #1 is genomics. But those artifacts live in SOURCE. Since LIVE should be self-contained, we need those copied in too. Hmm.
> 
> Strategy: I'll have this dispatch focus on:
> (a) spatial fixes (Priority 1-4 #1-2, #4-18, #20),
> (b) Visium ingest self-containment + SDRF metadata-integrity note (interim #6),
> (c) 4B/4C top-genes sign filter + generating script + Census batch log annotation (interim #2) — but that requires the 114 MB DE CSV from SOURCE. The analyst can read it from SOURCE read-only and write a small summary into LIVE. But it also needs the original top-genes table (small) copied. That's doable.
> 
> That's a lot for one agent. But this agent is capable; the spatial fixes are the core. Let me be realistic: one dispatch, clear priorities, tell it to do spatial first, then ingest, then 4B/4C if time permits. Actually, better to split into two parallel dispatches? They'd both write to different subdirectories of LIVE/work/single-cell-analyst (tables/figures/reports). Risk of conflict on run log. Keep sequential to avoid conflicts.
> 
> Another thought: the other agents' fixes (genomics 4A G7, Tahoe counts, clinical nothing, 4D prose) need separate dispatches. I'll handle after.
> 
> Let me dispatch single-cell-analyst now with a comprehensive prompt.
> 
> Impor
> *... [2,666 chars total]*

> Quota: 200,884,363,264 used of 214,748,364,800 → headroom ~13.86 GB. Good.
> 
> visium_sections_qc.h5ad = 450 MB. Copying to LIVE is fine (13.8 GB headroom, but the resume warned about quota crises). 450 MB is acceptable but let me consider: the reviewer asked for self-containment. Copying 450 MB brings LIVE to ~540 MB. That's fine relative to 13.8 GB. But the resume says "do not copy the full work tree" — 450 MB single input is not that. I'll allow it, but instruct the analyst to check quota and not copy anything else large.
> 
> Actually, alternative: instead of copying the 450 MB h5ad, vendor the *reproduction instructions* pointing to the read-only SOURCE path, and state in the report that the input is archived at SOURCE. But the reviewer flagged self-containment as a defect. The run-organization skill's standard is understandable/replayable six months later — a read-only predecessor path that may be pruned is weaker. Copying 450 MB is reasonable. Let it copy with a hardlink (`cp -l`) if the filesystem supports it — same BeeGFS, same user: hardlink would cost no quota. But hardlink across directories within same FS works; however the provenance scanner uses `p.resolve().is_relative_to(run_dir)` — a hardlink has no symlink resolution issue (it's a real path), so it would be included in MANIFEST with the same inode. Hardlink is ideal: no quota cost. But is `cp -l` allowed by hook? Probably. I'll instruct: try `cp -l`, fall back to `cp`.
> 
> Now let me write the dispatch. I'll be precise but not over-long. The analyst should read the reviewer report itself.
> 
> Key requirements:
> 1. Do NOT retrain the reference or re-run the mapping. Only table/plot recomputations from existing outputs.
> 2. Read reviewer report path.
> 3. Apply Priority 1–4 items 1-18, 20 (spatial), plus ingest self-containment and SDRF note, plus 4B/4C fixes if feasible (read from SOURCE).
> 4. Produce report revision 2 with a changelog and corrected numbers.
> 5. Append to run log.
> 6. Keep 
> *... [2,859 chars total]*

> Important correction from the analyst: the reviewer's "tumour sections are denser" correction is nuanced — tumour has higher sequencing counts (4,215 vs 2,123) but lower estimated cell abundance (6.42 vs 7.13). So "tumour denser" was wrong in terms of cell abundance but right in terms of counts. The revised report states this. Good.
> 
> Also the all-NaN arithmetic: 47,448 × 28 = 1,328,544 (mean + q05 columns). So 28 columns is right; the reviewer's "664,272 is 47,448 × 14" was the 14 mean columns only. The analyst now states 1,328,544/1,328,544 (100% of 28 mean+q05 columns; 73.7% of all obs cells). Good.
> 
> Composition pp residual is exactly 0.0. Relative composition sums −40.1% tumour — hmm, that's odd: relative-composition sums should be ~0 too if all 14 covered... Actually composition sensitivity is relative abundance (percent change in composition proportions), which need not sum to zero because it's ratios. Fine.
> 
> Now I should verify the revised report and key outputs myself. "Trust but verify." Let me:
> 1. Check the report revision 2 sections and changelog.
> 2. Verify the new edge table numbers (NK −18.55, endothelial −34.98).
> 3. Verify composition pp residual 0.
> 4. Verify figure regeneration (look at one figure).
> 5. Check the run log rows.
> 6. Check the 4B/4C rebuilt table (0 wrong sign).
> 7. Check quota.
> 
> Let me do a batch of checks.

> 

> The report is well-structured. Note item 7 says BH q 0.0013 with CI including 0 — contradictory? If permutation p at floor and CI includes 0, calling it "significant by permutation but CI includes 0, so not an enrichment" is a defensible reconciliation.
> 
> Let me now verify the actual tables independently:
> - composition pp residual sums to 0
> - edge table NK/endothelial values
> - 4B/4C top genes sign filter
> - stratification audit columns median_total_counts
> - figures regenerated and Panel A legend
> - quota
> 
> Let me run a Python check (I'm allowed to use Bash for session file management; this is verification of specialist outputs, arguably specialist work. But "trust but verify" requires checking actual changes. A simple data check is verification, not new analysis. I'll do minimal checks.)
> 
> Actually, per my role: "You have file tools (Read, Bash, Glob) ONLY for browsing workspace outputs from specialists and managing session files." Reading CSV summaries with Bash is browsing. Computing a sum is borderline but it's verification. I'll keep it lightweight.

> 

> Verified:
> - pp composition sums ~0 (1e-15) across all variants for all 14 types. Good.
> - Edge table: NK tumor +3.81 → −18.55; endothelial −16.04 → −34.98. Matches the analyst's report. Adjacent-normal NK +3.37 → +8.70; endothelial +2.34 → +9.88.
> - Stratification audit has both mean_ and median_total_counts columns — good.
> - Top genes 0 wrong-sign.
> 
> Now check the figures and report bottom line. Also check quota after copying the 450 MB h5ad.

> Quota used 201,345,511,424 of 214,748,364,800 → headroom 13.4 GB. Fine. Work dir 525M (includes 450M h5ad).
> 
> Wait — the figure timestamps for c2l panels are 23:51 (regenerated), neighborhood 23:43. But the report was updated at 23:56, after figures. Good.
> 
> But fig4e_neighborhood PNG is 465 KB vs earlier 441 KB — regenerated. Let me look at the new neighborhood figure to check Panel A legend and Panel C.
> 
> Also read the bottom line of the report. Then dispatch the reviewer for a re-review (short targeted verification) — the reviewer said "revise and resubmit"; a re-review is warranted but can be scoped to the changed items. I could ask the same reviewer agent to verify the revision via SendMessage? The tool description says to continue a previously spawned agent, use SendMessage with the agent's ID. But there's no SendMessage tool in my tool list! Only Agent. The result message says "use SendMessage with to: 'ae9db7d31d8cb49b1'". But SendMessage isn't in my available functions. So I must dispatch a fresh agent.
> 
> Given cost/time, a targeted re-review by a fresh scientific-reviewer focused on the 20 items and the revised report is appropriate. It can be scoped and shorter.
> 
> But before that, I need to handle the other panels' defects: 4A G7, 4B/4C (done by analyst), 4D prose, Tahoe counts, 4F none, Visium (done). And assemble upstream artifacts into LIVE.
> 
> Plan:
> 1. Inspect new neighborhood figure + report bottom line.
> 2. Dispatch targeted re-review of revision (fresh scientific-reviewer) — could run in parallel with upstream artifact assembly? The reviewer needs the artifacts present in LIVE to cite. Better: first assemble curated upstream artifacts into LIVE (fast file copy), then dispatch re-review over everything.
> 3. Dispatch fixes for genomics 4A G7 + Tahoe counts + 4D prose. These agents need their source data. I can copy their result trees into LIVE first, then have each agent fix in place.
> 
> Let me think about assembling upstream a
> *... [2,792 chars total]*

> The legend is improved: colour = compartment (red immune, blue context), hatch = CI includes 0. Panel C is now pooled ratio, y-axis says "(pooled ratio)", and x labels P10, P15, P16, P24, P25 — 5 donors. Good.
> 
> Now read report bottom line §8.

> The revised bottom line is much better and scientifically honest. One issue: line 531 says "high-CD276 regions in LUAD are modestly denser" — but the reviewer said tumour has lower total abundance than normal, and within tumour high-CD276 spots have +12% total abundance. So "modestly denser" refers to high vs low within tumour; that's fine, though could be confused with the section-level density. Given §4 corrected, acceptable.
> 
> Another issue: "endothelium -2.03 pp (0/12 sections positive, 0/5 donors)" — good.
> 
> Now proceed to assemble upstream artifacts in LIVE. Let me check sizes for reports/figures/scripts across agents.
> 
> Important: MANIFEST scan uses `p.resolve().is_relative_to(run_dir)`. If I copy files, they're real files. Good.
> 
> Plan for copies:
> - For each upstream agent: copy `results/reports/*.md`, `results/tables/*.csv`/`*.json` (excluding those >20 MB), `results/figures/*` (prefer PNG, skip PDFs maybe; PDFs 0.5-30 MB), `code/scripts/*.py`, and `logs/*.csv|*.log|*.md` selectively.
> 
> Let me list the reports and figures with sizes.

> Sizes are modest except fig4b PDF 28 MB (skip PDF, keep PNG 5 MB) and the 114 MB DE CSV.
> 
> Let me now copy curated artifacts. I'll use a shell script with rsync-like excludes via `cp` and `find`. Since hooks have been finicky, use simple relative paths after cd. I'll:
> 
> 1. For each agent, create dirs results/{tables,figures,reports}, code/scripts, logs.
> 2. Copy report .md files.
> 3. Copy figures: png + pdf except fig4b_umap PDF (28 MB).
> 4. Copy tables: all .csv/.json under 10 MB (use find -size -10M).
> 5. Copy scripts: all .py.
> 6. Copy key logs: for single-cell, liana_run_log.csv etc.
> 
> But careful: copying single-cell tables will overwrite the LIVE revised tables? The LIVE single-cell tables dir already has revised c2l tables. If I copy from SOURCE, I'd overwrite with the OLD (pre-revision) versions! Must exclude the visium/c2l/scrna tables that LIVE already has, or copy only missing files with `cp -n` (no clobber). Use `cp -n` to be safe, then the LIVE revised files win. But `scrna_*` revised files are in LIVE already? The analyst wrote `scrna_cd276_de_summary.csv`, `scrna_pseudobulk_de_top_genes.csv` into LIVE. `cp -n` preserves them. Good.
> 
> Also the LIANA tables don't exist in LIVE, so they'll copy.
> 
> For the 4B/4C report, the analyst may have updated the LIVE scrna report? Let me check LIVE reports: only visium ones and revision response. So copy scrna report from SOURCE with `cp -n`, unless the analyst updated it. It didn't. Fine — the top-genes correction is documented in the revision response.
> 
> Also should copy the upstream figures for 4B/4C/4D/S5A/4A/4F/Tahoe.
> 
> Let me also copy `work/single-cell-analyst/logs` selective: liana_run_log.csv lives in results/tables. Logs are useful for claims. Copy `*.log` files under, say, 5 MB.
> 
> Let's do it.

> Copied. single-cell-analyst grew to 686M because fig4b PDF 28 MB + pngs + tables (LIANA ~30 MB) + existing 525M. Fine.
> 
> Let me verify the copy of single-cell didn't overwrite revised LIVE files (cp -n should prevent). Check timestamps of revised tables e.g. visium_neighborhood_composition_pp_difference.csv.

> Quota now 201,518,616,576 → headroom 13.23 GB. Fine.
> 
> Now dispatch fixes for genomics 4A (G7 note), functional-genomics (Tahoe histology counts), and single-cell 4D/S5A prose (CXCR3 mention + arithmetic). These are small. I could dispatch three agents in parallel since they touch different directories.
> 
> For genomics: fix `01_verify_germline_cd276.py` hardcoded "69 all types / 65 GWAS" note and regenerate the CSV. But re-running the script may require the genetics MCP and data from the source run; it may take time and require the original data path. Alternatively, the specialist can correct the note from the existing reconciliation table and log the fix. The reviewer said "remove the hardcoded string; store the score/distance distributions and trait-label counts." Storing distributions requires re-parsing the E2G CSV (1.8 MB) which is now in LIVE — doable without MCP. The within-window score median/distance can be computed from `cd276_e2g_regulatory_elements.csv`? The reviewer noted that CSV has only 29 rows (score ≥0.02 subset), so the full distribution isn't there. The script `02_parse_encode_re2g_cd276.py` reads the raw ENCODE-rE2G file from source data. Is that raw file in LIVE? No. It could read from SOURCE read-only. That's acceptable for a correction but not self-contained. Hmm.
> 
> The pragmatic approach: dispatch genomics-analyst with permission to read SOURCE raw data read-only and write corrected artifacts into LIVE. It can recompute the distributions and trait-label counts, fix G7, and write a corrected report addendum.
> 
> For functional-genomics: correct the Tahoe report prose (11 LUAD / 1 SCLC / 10 other) and change "NON-MATERIAL data gap" to "not assessable / no evidence either way". Small.
> 
> For single-cell 4D/S5A: correct CXCR3 and arithmetic sentences in the LIANA report. The agent can just edit the report. Small.
> 
> Can I dispatch all three in parallel? Yes, different directories. Let me do that. Use model sonnet default.
> 
> Let m
> *... [3,649 chars total]*

> Wait — the genomics agent says the delivered union table has 7,332 rows; the reviewer said 29. The discrepancy: the reviewer may have inspected `cd276_e2g_regulatory_elements.csv` (29 rows), while the new table is `cd276_e2g_cd276_linked_all_839.csv`. Fine, clarified.
> 
> Now dispatch functional-genomics and single-cell 4D fixes in parallel.

> 

> Interesting: the LIANA agent says the reviewer's CXCR3 premise was false — CXCR3 does exist, but at lower rank. Good adversarial verification. Note it wrote `revision_response_to_reviewer.md` into the same LIVE reports dir — potentially overwriting the spatial revision response file! Let me check: the spatial analyst wrote `results/reports/revision_response_to_reviewer.md`, and the LIANA agent was instructed to write the same path. It probably overwrote it. Need to check and rename to keep both. Let me inspect.
> 
> Also the genomics agent and functional agent wrote their own in their own dirs, fine.
> 
> Let me check the single-cell reports dir.

> The file at 00:26 is 14,177 bytes and starts with the spatial review response (items 1–20), not the LIANA response. Hmm, timestamp 00:26 is after the LIANA agent finished (00:26). It may have appended the LIANA response to the existing file? Let me check the tail and grep for LIANA.

> The LIANA agent appended to the same file rather than overwriting. Both responses are preserved. Good — though the file now mixes scopes. Acceptable; it's a response log. I could rename to `revision_responses_single_cell_analyst.md`, but not necessary.
> 
> Now I need a targeted re-review of the revisions. The reviewer's verdict was "revise and resubmit", and the analyst claims all 20 items addressed. A re-review should verify the key corrections and the two agents' corrections. Given time, I'll dispatch a focused scientific-reviewer re-review:
> 
> - Verify the 20 spatial items are actually corrected in the revised report/tables.
> - Verify no new errors were introduced (e.g., composition 14 types, edge loop, BH correction).
> - Verify the 4A, Tahoe, LIANA corrections.
> - Verify the figures.
> - Confirm the run is now self-contained.
> - Give a final verdict: accept / accept with caveats / revise.
> 
> This should be shorter than the first review. Let me dispatch it.
> 
> Before that, check whether the report's claims about BH FDR etc. are accurate — the reviewer re-review will do that.
> 
> Also, the synthetic_test dir: did the analyst add README? Let me check quickly. And check `visium_c2l_mapping_history*.csv` deleted.
> 
> Let me dispatch the re-review.

> The re-review says ACCEPT WITH DISCLOSED LIMITATIONS, conditional on two text-level corrections:
> 1. Item 16: two header-only CSVs still exist while README says deleted.
> 2. Item 4: medians don't reproduce (7,545/3,708.5 vs reported 7,337/3,676; adjacent-normal 2,388/2,083.75 vs 2,326/1,945). Also N3 (five families vs 20 passes), N4, N5, N7.
> 
> These are text/artifact fixes. I should apply them. They're in the single-cell-analyst scope. But dispatching a whole agent for 3 small text changes is heavy; nevertheless I must not edit specialist outputs myself? The CSO shouldn't do analysis, but fixing a file is management. However the report is the specialist's artifact and the numbers must be recomputed correctly. The reviewer gave the correct medians — but I shouldn't just trust and paste. Better to dispatch the analyst again with a very short task: recompute the four medians, correct the changelog, delete the two header-only CSVs (or amend the README), fix "five families" → "20 passes", fix N5 by adding a small table with per-spot medians, and N7 by stating both projections. Also fix the run-log 664,272 row? It says the correction row coexists — acceptable, but could annotate.
> 
> This is a quick task. Let me dispatch it, and meanwhile I can start working on the final synthesis structure. But I need the corrections first for accurate claims. Actually claims can cite corrected artifacts after the fix.
> 
> Let me dispatch the analyst now (short prompt), then begin assembling the synthesis inputs (read all reports). I can read reports while the agent works? Agent calls are blocking unless run_in_background. I could run the fix in the background and read reports in parallel. The tool supports run_in_background: true. But then I need to wait for notification. Reading reports is something I'd do anyway. Let me run the fix in the background and read the upstream reports meanwhile.
> 
> Actually simpler: dispatch synchronously — it's small. Then read reports. Time is fi
> *... [2,015 chars total]*

> Now the review/revision loop is complete. Let me update the todo list and move to final synthesis.
> 
> Before synthesis, I need to read all the reports to build the panel-by-panel comparison. I have not read: 4A, 4B/4C, 4D/S5A, 4F, Tahoe, and the final re-review. Let me read them. They total ~30-40k words; that's a lot but necessary. The reports:
> - genomics 4A 18.4 KB + revision
> - scrna 4B/4C 12 KB
> - LIANA 4D/S5A 37.8 KB
> - TCGA 4F 13.2 KB
> - Tahoe 8.2 KB
> - Visium c2l 38.9 KB (already read sections)
> - Visium ingest 13.7 KB (partially)
> - Interim review 35.7 KB (read outline + key parts)
> - Full review 30 KB (read sections 7, 9)
> - Re-review ~? (read summary only)
> 
> For the final report I need precise numbers. Let me read the reports efficiently — focus on abstracts/bottom lines/results tables rather than every line. Use Grep for headings and Read key sections.
> 
> Let me start with 4A summary, 4B/4C, 4D, 4F, Tahoe. Then the re-review verdict.

> 

> 

> 

> 

> Now 4F and Tahoe key sections, and the re-review verdict details.

> Note: the 4F report header says Run: 080518 (R0), not LIVE. It's a copied artifact. I should have the clinical-trialist fix provenance too, or note it. The re-review said 4F verified and no change required. But for self-containment, the header should say the LIVE run. Minor. I could add a note in the final report. Actually better to have the clinical agent update the header and paths, but that's cosmetic. I'll note it in FINAL_REPORT's provenance section.
> 
> Now Tahoe and the re-review's final verdict.

> Good. Now I have the essential content. Let me also read the re-review's final verdict section 4 header (the previous sed started at "### 4A" which is Section 3 maybe). Let me get the actual "## 4" or the verdict.

> Excellent. Note the re-review says "conditional on two text-level corrections" — which I just had the analyst fix (Item 16 and Item 4). I should verify those fixes are actually in place, then declare the review loop closed. Let me check:
> - header-only CSVs deleted.
> - changelog #4 medians updated to 7,545/3,708.5 and 2,388/2,083.75.
> - depth balance table exists.
> 
> Then write the FINAL_REPORT.md.
> 
> Let me verify quickly.

> All final corrections verified. The review loop is closed with ACCEPT WITH DISCLOSED LIMITATIONS.
> 
> Now the final synthesis. I need to:
> 1. Write `report/FINAL_REPORT.md` (the skill says `report/FINAL_REPORT.md`).
> 2. Panel-by-panel comparison to the paper.
> 3. Workflow diagram.
> 4. README update.
> 5. File claims (record_claims) with artifacts in LIVE.
> 6. Register artifacts (list_artifacts first).
> 7. Repo update and push.
> 
> Also the requirement file likely specifies the final deliverable location/name. Let me check `full_requirements.md` for the final report requirements to make sure I comply. Let me read it.

> Let me get oriented. I need to check the current state of the LIVE run directory and then write the FINAL_REPORT.md, file claims, update README/repo.
> 
> Let me first look at the current run directory structure and the artifacts available.

> Good. Disk headroom: size 201.5 GB used of 214.7 GB hard = 13.2 GB headroom. Fine.
> 
> Now I need the exact artifact paths for claims. Let me list the key artifacts. Also need to check reports.
> 
> Let me gather the key report files and key tables systematically. Rather than reading everything again (I have most key numbers in the summary), I should verify a handful of current values from the actual tables so the final report is accurate and claims cite real files.
> 
> Let me list the report files and key tables.

> The LIVE run has everything. Note `evidence/` is empty — I need to file claims. Also `report/` is empty — need FINAL_REPORT.md.
> 
> Let me quickly verify key numbers from the actual tables so the final report is accurate. Let me read the critical summary tables in one go.
> 
> Key numbers I need:
> 1. Panel 4A: 0/8 germline, 77 E2G elements, median score 0.0143083, median distance 241.1 kb
> 2. Panel 4B/4C: 413,996 cells, 80 donors, 15 types; 0/15 CD276 DE significant, min padj 0.2913
> 3. Panel 4D/S5A: pair status counts
> 4. Panel 4E/S5B: neighborhood results, composition pp differences, depth balance
> 5. Panel 4F: TCGA HRs
> 6. Tahoe: not assessable; DepMap values
> 
> Let me pull these concisely.

> The hooks block `2>/dev/null`. Let me avoid it.

> Good. Now I need 4F TCGA key values, the DepMap values, and the neighborhood robustness summary (mean % change, CI, FDR). Let me read those.
> 
> Also I should check the neighborhood robustness table for the tumour key numbers.

> The `cd work` failed because the second command ran from a different cwd (shell state doesn't persist, but the working dir should be the run dir...). Actually the error says "No such file or directory" for work — meaning cwd isn't the run dir. The first command in the pair worked with `cd work`? Wait the first result showed output including the failure line at top: "/bin/bash: line 0: cd: work: No such file or directory" then the TCGA output. So `cd work` failed but subsequent commands with relative paths worked from cwd. That means cwd is likely `/mnt/beegfs/xqinag/projects/TheVirtualBiotech/runs/20261021-204038-...` and there is no `work`? But ls showed work/ exists. Hmm — maybe cwd is the nested dir. The relative paths `clinical-trialist/results/...` worked, so cwd must be `work`. That explains: cwd already is `work`, so `cd work` fails.
> 
> So shell cwd = .../work. Let me use absolute paths or account for that. Let me check pwd.
> 
> Also need correct column name for BH q. Let me print columns.

> 

> Now I have the key numbers. Let me also read the re-review verdict and the strongest/weakest claims, plus check the interim review findings for panels 1-6, so FINAL_REPORT reflects them accurately. I have summary but let me read the rereview conclusion section.
> 
> Also need plan.json content to reference, and check whether inputs/query.txt exists (it doesn't — only plan.json). The run-organization skill says inputs/query.txt should have the user's turns verbatim. I can create it (CSO file management is allowed) to make the run self-contained. Let me check plan.json.
> 
> Let me read the re-review's key sections.

> Excellent. This is a comprehensive re-review. Now let me check whether the two conditions were actually applied (I recall they were). Let me verify: mapping history CSVs deleted, and the median values corrected in the 4E/S5B report.
> 
> Then check what other panels' reports say, briefly. I have the key numbers.
> 
> Let me verify N1 and N2 fix status.

> Both reviewer conditions were satisfied. Now I need to read the bottom-line sections from the panel reports: 4A §4 (line 186), 4D §9 (line 463), 4B/4C summary, 4E/S5B bottom line, 4F report bottom line, Tahoe status.
> 
> Let me read those specific sections.

> I have a solid understanding. Let me also check the 4F report and Tahoe status bottom line. And check the interim review (panels 1-6) for any remaining unaddressed items. But I think the re-review is the authoritative final check.
> 
> Let me read 4F bottom line and Tahoe status conclusion.
> 
> Then write the FINAL_REPORT.
> 
> Also need workflow diagram. The run-org skill wants `report/FINAL_REPORT.md`. Let me also create `inputs/query.txt` (verbatim user turns). Hmm — I don't have exact verbatim text of user turns. I could write a summary, but that would be inaccurate. Better: leave it, or write the task as provided in the resume file? The skill says inputs/query.txt = user's turns verbatim. I can reconstruct the last actual user instruction from the summary: "read the resume file in full, state briefly that it was read, then continue execution..." That was a continuation instruction. I'll create query.txt with the verbatim resume file content? No — that's config, not query.
> 
> Actually, `inputs/plan.json` exists. Let me check it — the earlier `cat inputs/plan.json` failed because cwd is `work`. Let me cat `../inputs/plan.json`.
> 
> Let me also verify the MANIFEST status and whether README.md/audit.html exist (they don't; they're generated).
> 
> Next steps:
> 1. Read 4F + Tahoe bottom line.
> 2. Read inputs/plan.json.
> 3. Write FINAL_REPORT.md.
> 4. Register artifacts + record claims.
> 5. Update MANIFEST status? The run has an orchestrator that generates README/audit. I can't run that generator. I'll note it.
> 6. Git update and push — that's a repo-wide action affecting shared state. The resume instructions explicitly say "README/repo update and push" and "No approval checkpoint needed" — so push is authorized by the user's instructions. But I should check which repo and what branch. Let me check git status in the repo root.
> 
> Let me proceed.

> Now I have everything needed. Let me write the FINAL_REPORT.md.
> 
> First, one issue: the TCGA report's header says `Run: 20261021-080518-round-2-of-the-b7-h3-cd276-lung-27ef6dcf` — stale. I said optional cleanup. Since edits to specialist reports should be done by specialists, and this is a provenance header rather than analysis, I can note it in the final report as a disclosed provenance issue instead of editing the specialist's report. Actually the cleanest is to disclose it. But it's a trivial text fix that improves auditability. As CSO I manage session files; specialist work files should be theirs. I'll disclose it in FINAL_REPORT with an explicit note, which is honest and sufficient.
> 
> Also `scientific_review_interim_panels1-6.md` is at the agent root — I'll leave it but reference it; or move it into results/reports. Moving a file would change MANIFEST paths. Better leave and note.
> 
> Now let me think about the final recommendation. This is the key intellectual work — but as CSO I must synthesize from specialist findings, not do new analysis. That's fine.
> 
> Evidence summary:
> - Genetics (4A): No germline credible-set support in LUAD/SCLC (0/8 studies, 0/67 L2G). E2G annotation present but annotation-only (77 elements, median score 0.014, median distance 241 kb).
> - Atlas/DE (4B/4C): 413,996 cells; CD276 low overall; highest detection in fibroblasts and normal macrophages; 0/15 DE contrasts significant (min padj 0.291); fibroblast DE untestable (1 normal donor).
> - LIANA (4D/S5A): No unique signalling. Rank-based enrichment of ECM/proteolysis (THBS2–CD47, PLAU–PLAUR etc.) in CD276-detected CAFs; confounded by myCAF marker score and depth; weak in SCLC.
> - Spatial (4E/S5B): absolute neighbour immune increases are density-driven (+12.0% total abundance); composition shows malignant +3.79 pp and donor-concordant endothelial −2.03, NK −0.49, macrophage −0.40, monocyte −0.23, mast −0.24; DC +0.49 pp. No selective T-cell enrichment. Adjacent-normal split
> *... [5,417 chars total]*

> 

> 

> Now I have the exact paper benchmark values: OS HR 1.62 [1.05–2.48] p=0.028, DSS 1.82 [1.06–3.15] p=0.031; 566 patients; 250 reference epochs / 10,000 spatial epochs on H100; expected ~8 cells/spot.
> 
> Our values: OS adjusted 1.44 (0.92–2.26) p=0.106; unadjusted 1.80 (1.19–2.71) p=0.0051. DSS adjusted 1.39 (0.79–2.44) p=0.249; unadjusted 1.86 (1.10–3.13) p=0.021.
> 
> Interesting: unadjusted HRs (1.80, 1.86) are close to the paper's (1.62, 1.82) — suggesting the paper may not have fully adjusted, or used a different cohort subset. Direction and magnitude concordant; significance is achieved unadjusted but lost on adjustment. This is a good pipeline plausibility check: the paper quotes adjusted HRs of 1.62/1.82 which sit between our unadjusted and adjusted estimates. So pipeline is plausible.
> 
> Now let me write the FINAL_REPORT.md. It needs:
> - data/provenance
> - panel-by-panel comparison to paper
> - workflow diagram (ASCII/mermaid)
> - limitations
> - bottom-line recommendation
> - round-1 comparison (supports/revises/contradicts)
> - claim anchors [[claim:Cn]] — but I file claims after, and anchors must match. I'll write the report with anchors, then record claims. Order: write report first with anchors, then record. But record_claims needs exact paths — I have them.
> 
> Actually better: record claims first (so I know IDs and that they validate), then write report with anchors. But claims reference text I will write. Either order works. Let me draft claims list carefully with real paths, record them, then write the report using those IDs. Hmm, the instruction says "Write your synthesis with an inline anchor after each claim" then record. Both fine. I'll write the report file first (it's a file, not my response), then record claims, then my chat response will also contain anchors. To be safe, I'll record claims first so any path rejection is caught before I finalize prose. Actually claims' `text` is independent of the report file. Let me record claims first
> *... [7,289 chars total]*

> The full review doesn't explicitly mention LoF constraint. Let me check the interim review.

> The interim reviewer's assessment:
> - (a) LoF-constraint framing: DOES NOT RECUR — panel 4A makes no LoF constraint/essentiality claim.
> - (b) materiality: "not a recurrence in substance, but reword" — and indeed the Tahoe report now says "not assessable / no evidence either way" (I verified line 8 and 70-83). So the reword was applied.
> 
> Good, that's a claim with evidence.
> 
> Now let me write FINAL_REPORT.md. This should be thorough. Let me plan the structure:
> 
> 1. Executive summary / bottom line
> 2. Run provenance and how to read this package
> 3. Analysis workflow (diagram)
> 4. Panel-by-panel comparison with the paper (4A, 4B/4C, 4D/S5A, 4E/S5B, 4F, plus DepMap/Tahoe)
> 5. Cross-panel synthesis: what the evidence says about CD276
> 6. Round-1 comparison: supports / revises / contradicts
> 7. Scientific review outcome and what changed
> 8. Limitations and disclosed deviations
> 9. Recommendation
> 10. Artifact index / reproducibility
> 
> Let me get exact paper values from requirements: OS 1.62 [1.05–2.48] p=0.028; DSS 1.82 [1.06–3.15] p=0.031; 566 patients; 250/10,000 epochs; ~8 cells/spot; 1,000 permutations; top 10%, p<0.01, ≥3 methods; QC 300–9,000 genes, ≤15% mito, 10,000 cells/donor, 3,000 HVGs, Harmony.
> 
> I need to check whether the 4B/4C analysis followed the paper's QC. Let me quickly grep for the final cell counts post-QC to report accurately.
> 
> Also need the deconvolution 14 cell types list and section counts. I have section summary.
> 
> Let me grab: scrna_cell_donor_audit (final counts), and the QC stages.

> Now I have all the numbers. Let me write the FINAL_REPORT.md.
> 
> Note: "raw_pull 502,306" vs summary earlier said 413,996 final. Raw 502,306 → post-QC 494,982 → post-downsample 413,996. Good.
> 
> I should note that the ratio: 413,996 cells / 80 donors / 15 cell types.
> 
> Let me now write the report. It should be comprehensive but not bloated. I'll aim for a well-structured ~350-450 line report.
> 
> Key structure and content:
> 
> # Final Report — Round 2, B7-H3 (CD276) lung cancer case study
> Run id, date, status.
> 
> ## 1. Bottom line
> ## 2. What was done (workflow diagram)
> ## 3. Panel-by-panel: analysis vs paper
> ## 4. Cross-panel synthesis
> ## 5. Round-1 comparison
> ## 6. Review trail
> ## 7. Deviations, limitations, data gaps
> ## 8. Recommendation
> ## 9. Artifact index
> 
> I'll include claim anchors [[claim:Cn]].
> 
> For the workflow diagram, use a mermaid block and an ASCII fallback. Rendered in markdown, mermaid may or may not render; provide ASCII text diagram to be safe. Actually a code block with ASCII is most portable.
> 
> Let me write it.
> 
> Important: be precise about "paper claims" — I only know them from the requirements file (paper values quoted) and the panel requirements. I should state that the paper comparison uses the panel specifications and the explicitly quoted values in the requirements, not the paper full text (which was not accessible — web disabled).
> 
> Paper expectations per requirements:
> - 4A: germline credible sets + E2G lung regulatory elements. Paper caption conflates them.
> - 4B/4C: full rebuild, QC spec, DE.
> - 4D/S5A: LIANA rank_aggregate, 1,000 perms, top 10%, p<0.01, ≥3 methods; unique signalling to B7-H3+ CAFs; SCLC main, LUAD supplemental.
> - 4E/S5B: Visium 12 tumour + 10 adjacent normal; exclude CD276 from reference; 250/10,000 epochs; ~8 cells/spot; k=6, top/bottom quartile, percent change in neighbouring immune abundance.
> - 4F: TCGA LUAD 566 patients; quartiles; Cox adjusted age/stage/sex; OS 1.
> *... [2,694 chars total]*

> Now I have everything. Let me write the final report.
> 
> One more thing: the number of cell types in deconvolution is 14 (erythrocyte dropped). The section summary has 14 compartments? Earlier the composition table has 14 compartments: T, B, NK, macrophage, monocyte/myeloid, DC, mast, neutrophil, plasma, fibroblast, epithelial, endothelial, malignant, stromal/other = 14. Yes.
> 
> Let me write FINAL_REPORT.md now. I'll place claim anchors as I go.
> 
> I need to be careful: anchors like [[claim:C1]] must match filed IDs.
> 
> Let me draft the claims carefully with exact paths relative to run dir:
> 
> - work/genomics-analyst/results/tables/cd276_round2_germline_verification.csv
> - work/genomics-analyst/results/tables/cd276_e2g_within_window_score_distance_summary.csv
> - work/genomics-analyst/results/tables/cd276_e2g_within_window_score_distance_distribution.csv
> - work/genomics-analyst/results/figures/fig4a_genetics_e2g_cd276.png
> - work/genomics-analyst/results/reports/cd276_panel4a_report.md
> - work/single-cell-analyst/results/tables/scrna_cell_donor_audit.csv
> - work/single-cell-analyst/results/tables/scrna_cd276_de_summary.csv
> - work/single-cell-analyst/results/tables/scrna_cd276_expression_by_celltype.csv
> - work/single-cell-analyst/results/tables/scrna_de_testability_by_celltype.csv
> - work/single-cell-analyst/results/tables/liana_pair_status_counts.csv
> - work/single-cell-analyst/results/tables/liana_high_vs_low_differential_summary.csv
> - work/single-cell-analyst/results/tables/liana_b7h3_caf_definition.csv
> - work/single-cell-analyst/results/figures/fig4d_liana_sclc_caf_b7h3.png
> - work/single-cell-analyst/results/figures/figs5a_liana_luad_caf_b7h3.png
> - work/single-cell-analyst/results/tables/visium_c2l_section_summary.csv
> - work/single-cell-analyst/results/tables/visium_c2l_spot_abundances.parquet
> - work/single-cell-analyst/results/tables/visium_c2l_training_convergence.csv
> - work/single-cell-analyst/results/tables/visium_neighborh
> *... [3,877 chars total]*

> Now file claims. I have claim IDs C1-C20. Let me write them carefully with real paths and content matching the anchors.
> 
> Anchors used in the report: C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11, C12, C13, C14, C15, C16, C17, C18, C19, C20. Good — exactly 20 claims.
> 
> Let me record them.
> 
> C10 includes "+12.0% total abundance" — that's from composition_pp_difference.csv total_abundance_pct row (12.020, CI -1.659 to 25.99). And T/B/DC/neutrophil from robustness.csv. Good.
> 
> C19: reviewer verdict — cite review_round2_rereview.md. Also used in the "verdict accept" mention and the statistical limitations. Text: "The re-review verified 18 of 20 spatial items, one with correction and one contradicted... and accepted with disclosed limitations." Strong.
> 
> Wait, in the report I used [[claim:C19]] twice: once in "no evidence of T-cell recruitment... [[claim:C19]]" — no, let me check. In 4E comparison: "The reported per-section abundance is also lower in tumour ... [[claim:C19]]". Hmm, that's wrong — C19 is the reviewer verdict. I need a claim for the abundance comparison. Let me fix the report anchor to a new claim C21 for the tumour-vs-adjacent-normal abundance comparison, or re-map.
> 
> Let me re-check the anchors:
> - 4E comparison paragraph: "...the opposite of what a naive 'tumour is more cellular' reading would predict..."[[claim:C19]] → should be a claim about section-mean abundance 6.48 vs 6.73 and depth ratio. Let me add C21.
> - Section 6 review trail: uses [[claim:C19]] at the end of the intro sentence — that's the reviewer verdict claim. Good.
> - Section 7 statistical limitations: "(...floor of 1/1001 = 0.000999)[[claim:C19]]" — that's also citing the reviewer/report for the caveat. Could reuse C19 but text doesn't match. Better add C22 for the statistical limitations disclosure.
> 
> Let me restructure: I'll add:
> C21: Tumour sections have lower mean estimated cell abundance than adjacent-normal (mean of section means 6.48 vs 6.73) despite ~1.8
> *... [2,609 chars total]*

> 

> 

> Line 147 needs C21 instead of C19. Let me edit using the whole line fragment precisely (the apostrophe may be a typographic issue). I'll replace just `biology.[[claim:C19]]` — but ensure uniqueness. Let me use a shorter unique string: `interpreting counts as biology.[[claim:C19]]`.

> 

> I need to re-file the claims with kind "artifact" instead of "report". Let me first check the artifacts list to get exact paths, then re-issue record_claims.
> 
> Let me first read the FINAL_REPORT.md to recover the exact claim texts I need to file. Actually, my summary says I had 22 claims. I need to reconstruct them. Let me read the report and the artifacts list.
> 
> Let me do list_artifacts and read the report.

### Sub-agent Traces
- **single-cell-analyst** — 9385.07s (510 messages)
- **scientific-reviewer** — 437.63s (208 messages)
- **single-cell-analyst** — 1361.42s (558 messages)
- **genomics-analyst** — 513.91s (225 messages)
- **functional-genomics-analyst** — 319.66s (171 messages)
- **single-cell-analyst** — 812.31s (346 messages)
- **scientific-reviewer** — 425.07s (221 messages)
- **single-cell-analyst** — 378.84s (203 messages)
